Literature DB >> 25298939

Inhibition of biofilm formation and lipase in Candida albicans by culture filtrate of Staphylococcus epidermidis in vitro.

Sayan Bhattacharyya1, Prashant Gupta2, Gopa Banerjee2, Amita Jain2, Mastan Singh2.   

Abstract

BACKGROUND: Candida spp. are fourth most common cause of bloodstream infection in developed countries and emerging agents of fungemia in developing countries, with considerable attributable mortality. Candidemia is associated with the formation of complex, structured microbial communities called biofilms. Biofilm formation makes treatment difficult due to improper drug penetration and factors like high cost and adverse effects of antifungal drugs available. Hence, low-cost alternatives are urgently required to treat device-associated invasive candidiasis.
OBJECTIVES: To study the effect of culture filtrate of Staphylococcus epidermidis on biofilm formation and lipase expression of Candida albicans in vitro.
MATERIALS AND METHODS: Yeast cells isolated from clinical samples were suspended to a turbidity of 10(6) in (a) Yeast extract-peptone-dextrose (YPD) broth and (b) culture filtrate, and 100 μl of each were dispensed in separate wells of microtiter plate. After repeated washing and reloading with respective liquid media, readings were taken spectrophotometrically. To check for lipase inhibition, yeasts were incubated overnight in YPD and filtrate and subcultured on media containing Tween-80 and CaCl2. Positive lipase activity was denoted by haziness around colonies.
RESULTS: Mean reading of C. albicans in YPD broth was 0.579 while the same when yeasts were suspended in S. epidermidis culture filtrate was 0.281 (P < 0.05 by Z-test of significance). Lipase of C. albicans was inhibited by culture filtrate. Filtrate was found to be nontoxic to human cell line.
CONCLUSIONS: Culture filtrate of S. epidermidis can hence pave the way for development of new strategies to inhibit biofilm formation in device-associated candidemia.

Entities:  

Keywords:  Biofilms; Candida spp.; Staphylococcus epidermidis

Year:  2014        PMID: 25298939      PMCID: PMC4181128          DOI: 10.4103/2229-516X.140721

Source DB:  PubMed          Journal:  Int J Appl Basic Med Res        ISSN: 2229-516X


INTRODUCTION

Candida spp. is a common cause of device associated bloodstream infection in developed and developing countries.[1] This disease has a tremendous attributable mortality in the order of 30–40% according to available scientific literature.[2] Invasive candidiasis is generally associated with the formation of complex microbial communities, also known as biofilms over indwelling intravascular devices.[3] Biofilms are sessile communities consisting of microcolonies of yeast cells and an exopolymeric noncellular polysaccharide matrix secreted by the yeasts.[4] Candida albicans is the most common species of in the genus Candida implicated in invasive candidiasis, in at least 5070% cases, although other species are also responsible.[5] Invasive candidiasis makes therapy very difficult, owing to factors like defective penetration of antifungal drugs through biofilms by forming a reaction-diffusion barrier and high cost of drugs available, like the echinocandins.[67] Moreover, antifungal drugs like amphotericin B have major adverse effects like nephrotoxicity and other ill-effects on health.[8] Intravascular catheters and other devices colonized with C. albicans can be removed, but this is not always feasible and antifungal treatment should be an adjunct to it.[9] Hence, low-cost safer alternatives are the need of the hour for treatment of device-associated invasive candidiasis. Lipase enzyme expressed by C. albicans is one of the major virulence factors of the pathogen and its inhibition can be a strategy to abrogate infection by this pathogen.[10] The present study was designed to evaluate the effect of filtrate of culture supernatant of Staphylococcus epidermidis on the biofilm formation and lipase expression of C. albicans in vitro.

MATERIALS AND METHODS

Type, time, design and place of study

This was a laboratory-based observational study, carried out in the Department of Microbiology, King George's Medical University (KGMU), Lucknow, Uttar Pradesh, India. The study was conducted from July 2011 to June 2013.

Isolation and identification of microorganisms

Routine microbiological culture medium (5% sheep blood agar plate) was used to grow S. epidermidis isolates from different samples such as pus, blood, urine, and others. To isolate C. albicans from various clinical samples such as blood, pus, and urine, Saboraud's dextrose agar slant with Emmon's modification (pH 7.0) was used. Ten isolates each of C. albicans and S. epidermidis were randomly selected for the study. S. epidermidis isolates were identified by observing Gram-positive cocci microscopically after performing Gram-stain from the colonies on solid plates, positive catalase, and negative tube and slide coagulase tests and also a negative mannitol fermentation reaction.[1112] C. albicans isolates were identified by positive germ tube test and production of a single terminal chlamydospores on Corn Meal agar plate (Dalmau slit inoculation technique) after aerobic incubation at 25°C for 48 h.[13]

Test for biofilm formation in Candida albicans

The microtiter plate model, as proposed by Ramage et al., was employed for biofilm formation and its inhibition in vitro.[14] At first, yeast isolates were grown in YPD Broth (1% yeast extract, 2% peptone, 2% dextrose, w/v) overnight at 37°C. S. epidermidis isolates were suspended in YPD Broth (1 loopful of the colony in 2 ml broth) and centrifuged at 3000 rpm for 5 minutes. After that, the supernatant was filtered by passing it through the membrane filter of pore size 0.22 μm (Micro-Por Minigen Syringe Filter, Genetix Biotech Asia, New Delhi). Then yeast cell turbidity was adjusted to 106 cells/ml in (a) YPD broth, (b) S. epidermidis culture filtrate. Then 100 μl of each set of suspension was dispensed in separate wells of a flat-bottomed 96-well polystyrene microtiter plate (Nunclon A/S, Kampstrupvej, Denmark). Sterile physiological (0.85%) saline was added in a well as a negative control. After incubating for 90 min at 37°C, the wells were washed thrice with phosphate-buffered saline (PBS, pH 7.2) to remove non-adherent yeast cells and wells were reloaded with respective sterile liquid substrates. Washing and reloading was repeated at intervals of 24 h and 48 h. After 48 h, wells were washed thrice with PBS and stained with 100 μl of 1% safranine (weight/volume) in 95% ethanol for 1 min. After washing off excess stain with PBS, the wells were observed under inverted microscope under ×200 magnification.[14] Subsequently their readings (optical densities) were also measured spectrophotometrically at a wavelength of 450 nm ultra violet light (iMark MicroPlate reader, Bio-Rad, USA). The first round of tests was carried out with C. albicans ATCC 90028 strain and then with randomly selected clinical isolates. All tests were carried out 3 times.

Test for lipase inhibition

The test for inhibition of lipase was carried out by subculturing yeasts incubated overnight in (a) YPD and (b) culture filtrate on Muhsin's solid medium containing Tween-80 and CaCl2 .[15] A positive lipase activity was defined by a zone of haziness around yeast colonies on the medium.

Toxicity assay

The toxic effects of the filtrate were studied by inoculating 100 μl of the filtrate on Hep-2 (human laryngeal epithelioma) cell line monolayer in small polystyrene vials, incubating it for 1 h at 37°C, washing thrice with PBS, reloading the vials with 2 ml eagle's minimum essential medium, reincubating at 37°C, and periodic observation of the monolayer at 6 hourly intervals under an inverted microscope (×40 magnification). An uninoculated monolayer was kept as control. Experiments were repeated 3 times.

RESULTS

As observed by both methods (microscopically and spectrophotometrically), biofilm formation in C. albicans was significantly reduced by crude culture filtrate of S. epidermidis, in vitro. The difference in mean values (optical density [OD] readings) of yeasts in YPD and the culture filtrate were calculated by Z-test of significance.[16] The differences were found to be highly statistically significant. Mean OD of Candida tropicalis in YPD and culture filtrate were 0.579 and 0.281, respectively (P < 0.05). The results were found to be reproducible when performed in triplicate. The values have been shown in Table 1.
Table 1

Optical density reading of C. albicans in YPD and culture filtrate

Optical density reading of C. albicans in YPD and culture filtrate Lipase activity was found to be inhibited by culture filtrate of S. epidermidis. There was no zone of haziness around colonies subcultured from the culture filtrate in repeated experiments [Figures 1 and 2].
Figure 1

Haziness around Candida albicans colonies subcultured from the culture filtrate of Staphylococcus epidermidis

Figure 2

No haziness around colonies subcultured from yeast extract-peptone-dextrose (without Staphylococcus epidermidis filtrate)

Haziness around Candida albicans colonies subcultured from the culture filtrate of Staphylococcus epidermidis No haziness around colonies subcultured from yeast extract-peptone-dextrose (without Staphylococcus epidermidis filtrate) There was no observable change in morphology or cytopathic effect on of Hep-2 cells inoculated with the culture filtrate after periodic observation for 2 days compared to control vial. Thus, the crude filtrate was found to be nontoxic to host cells [Figures 3 and 4].
Figure 3

Hep-2 cell line incubated with Staphylococcus epidermidis culture filtrate

Figure 4

Similar picture (here also no cytopathic effect) when Hep-2 cell line is incubated with negative control (saline)

Hep-2 cell line incubated with Staphylococcus epidermidis culture filtrate Similar picture (here also no cytopathic effect) when Hep-2 cell line is incubated with negative control (saline)

DISCUSSION

Invasive candidiasis is now regarded as the fourth most common cause of hospital-acquired bloodstream infection in the United States.[17] Very high incidence of nosocomial candidemia has also been reported from developing countries like Brazil.[18] In a study from North India, the incidence of candidemia was found to be about 45% among patients admitted in intensive care units.[19] Thus, the burden of this disease is considerable in both developed and developing countries. Candidemia is primarily caused by C. albicans, according to scientific literature available worldwide.[20] However, species other than C. albicans are also emerging as agents causing candidemia, and a report from North India indicated that C. tropicalis is the most common species associated with the condition.[21] This disease entity is associated with the formation of complex microbial communities called biofilms over indwelling devices like intravascular catheters.[22] Formation of biofilms renders treatment difficult due to improper penetration of antifungal drugs through biofilms and slow growth of biofilm-associated cells.[2324] Antifungal drugs available also have their own toxic effects which limit their routine use to treat this condition. For example, conventional amphotericin B is notorious for causing nephrotoxicity and hypokalemia and newer deoxycholate formulation is more expensive than the conventional one.[25] The echinocandins are effective against biofilms, but are prohibitively costly.[7] Hence, focus of researchers has shifted toward discovery of newer, low-cost, and safer alternatives in order to treat biofilm-associated candidemia. In this regard, it is worthy to mention that organochlorine derivatives (Aspirochlorine) derived from Aspergillus flavus have been shown to inhibit C. albicans growth in vitro.[26] Similar inhibition of candidal biofilm has been shown by pyocyanin and lipopolysaccharideof Pseudomonas aeruginosa.[2227] In a mixed environment, the slime produced by S. epidermidis has been documented to facilitate adhesion of C. albicans to indwelling devices. Conversely, C. albicans also shield the bacterium from the action of vancomycin.[28] However, there is no study evaluating the effect of secreted substances by S. epidermidis broth culture on candidal biofilm formation and lipase expression. Similar inhibition has been shown when yeasts were grown in culture filtrate of A. flavus.[29] This filtrate was found to be nontoxic and hence can be precoated over the surface of indwelling devices to impair biofilm formation by C. albicans. Further studies are required in this context to characterize the inhibitory substances in the crude filtrate and further check for host toxicity on animal systems.
  23 in total

Review 1.  Intravascular catheter-related infections: advances in diagnosis, prevention, and management.

Authors:  Issam Raad; Hend Hanna; Dennis Maki
Journal:  Lancet Infect Dis       Date:  2007-10       Impact factor: 25.071

2.  Extracellular enzyme activities of dermatophytes and yeast isolates on solid media.

Authors:  T M Muhsin; A H Aubaid; A H al-Duboon
Journal:  Mycoses       Date:  1997-12       Impact factor: 4.377

3.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

4.  Aspirochlorine class compounds from Aspergillus flavus inhibit azole-resistant Candida albicans.

Authors:  Paul Klausmeyer; Thomas G McCloud; Kenneth D Tucker; John H Cardellina; Robert H Shoemaker
Journal:  J Nat Prod       Date:  2005-08       Impact factor: 4.050

5.  Penetration of Candida biofilms by antifungal agents.

Authors:  Mohammed A Al-Fattani; L Julia Douglas
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

6.  Attributable mortality of nosocomial candidemia, revisited.

Authors:  Olafur Gudlaugsson; Shane Gillespie; Kathleen Lee; Jeff Vande Berg; Jianfang Hu; Shawn Messer; Loreen Herwaldt; Michael Pfaller; Daniel Diekema
Journal:  Clin Infect Dis       Date:  2003-10-08       Impact factor: 9.079

7.  Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland.

Authors:  Lena Rós Asmundsdóttir; Helga Erlendsdóttir; Magnús Gottfredsson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  In-vitro Inhibition of Biofilm Formation in Candida albicans and Candida tropicalis by Heat Stable Compounds in Culture Filtrate of Aspergillus flavus.

Authors:  Sayan Bhattacharyya; Prashant Gupta; Gopa Banerjee; Amita Jain; Mastan Singh
Journal:  J Clin Diagn Res       Date:  2013-10-05

9.  Evidence of nosocomial spread of Candida albicans causing bloodstream infection in a neonatal intensive care unit.

Authors:  D R Reagan; M A Pfaller; R J Hollis; R P Wenzel
Journal:  Diagn Microbiol Infect Dis       Date:  1995-04       Impact factor: 2.803

10.  Pseudomonas aeruginosa lipopolysaccharide inhibits Candida albicans hyphae formation and alters gene expression during biofilm development.

Authors:  H M H N Bandara; B P K Cheung; R M Watt; L J Jin; L P Samaranayake
Journal:  Mol Oral Microbiol       Date:  2012-10-12       Impact factor: 3.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.